Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Asthma Drugs Market Research Reports

Titlepublishedprice

United States Doxofylline (API) Market Report 2016

By QYResearch Group
"...... r each player, covering - Fuan Pharmaceutical Group( Ningbo Team Pharmaceutical Co., Ltd. ) - Ami Life Sciences Pvt. Ltd. - Suven Life Sciences Limited - Delta Finochem Pvt Ltd - Anhui Langxi Lianke Industrial C......"
30-Nov-2016$3800

Global Asthma Drugs Sales Market Report 2016

By QYResearch Group
"...... ries, with sales, price, revenue and market share for each player in these regions, covering - GlaxoSmithKline - Sanofi - Roche & Novartis - Teva - Merck - AstraZeneca - Boehringer Ingelheim - ......."
30-Nov-2016$4000

Global Asthma Drugs Market Research Report 2016

By QYResearch Group
"...... et, with Production, price, revenue and market share for each manufacturer, covering - GlaxoSmithKline - Sanofi - Roche & Novartis - Teva - Merck - AstraZeneca - Boehringer Ingelheim Ma......"
23-Nov-2016$2900

Global Montelukast Sodium Market Professional Survey Report 2016

By QYResearch Group
"...... consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering......"
23-Nov-2016$3500

India Montelukast Sodium Market by Manufacturers, Type and Application, Forecast to 2021

By Global Info Research
"...... thma, exercise-induced bronchoconstriction, and allergic rhinTechnologyis. Scope of the Report: This report focuses on the Montelukast Sodium in India market. This report categorizes the market based on manufacturers, type and a......"
10-Nov-2016$4480

Vannair -Drug Insights, 2016

By Delve Insight
"...... des the Vannair sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Vannair, patents information and exclusivity data, route of synthesis, competitive lands......"
01-Nov-2016$1000

Asthma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... the market and pipeline status of the drugs around the Asthma to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight's Report provides the histor......"
01-Nov-2016$2000

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

By GBI Research
"...... se control and reduce the severity of symptoms, and a number of inhalational therapeutic options are available. Current asthma treatment options are able to provide the majority of patients with a sufficient level of disease control. Additionally, sc......"
01-Nov-2016$6995

Asthma-API Insights, 2016

By Delve Insight
"...... market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have strict guidelines for API manufacturing 'Process......"
01-Nov-2016$1250

Asthma - Market Insights, Epidemiology and Market Forecast-2023

By Delve Insight
"...... utics market revenue; average cost of therapy, treatment practice and Asthma forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Asthma till 2023. ......"
01-Nov-2016$4950

Avail upto 50% Discount on below Publisher Reports.